A trial looking at the treatment of SOF/GS-5816 for 12 weeks in patients with hepatitis C infection

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-001683-35

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objectives of this study are: - To evaluate the efficacy of treatment with SOF/GS-5816 for 12 weeks in subjects with chronic HCV infection as measured by the proportion of subjects with SVR12 - To evaluate the safety and tolerability of treatment with SOF/GS-5816 for 12 weeks


Critère d'inclusion

  • Chronic hepatitis C virus infection